Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Seiffert

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Blood|July 15, 1996
Two functionally distinct pools of vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granulesD Seiffert, R R Schleef
Biochimica Et Biophysica Acta|May 30, 1991
Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectinD Seiffert, D J Loskutoff
Thrombosis Research|June 4, 1998
Role of vitronectin and its receptors in haemostasis and vascular remodelingK T Preissner, D Seiffert
Applied Microbiology and Biotechnology|May 1, 1993
Biosafety investigations in an r-DNA production plantE K Weibel, B D Seiffert
Gene|December 8, 1993
Organization of the gene encoding mouse vitronectinD Seiffert, J Poenninger, B R Binder
The Journal of Cell Biology|September 1, 1990
Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitorD Seiffert, N N Wagner, D J Loskutoff
Histochemistry and Cell Biology|March 1, 1996
Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytesD Seiffert, G M Bordin, D J Loskutoff
Current Opinion in Drug Discovery & Development|December 1, 2001
Progress towards testing the amyloid hypothesis: inhibitors of APP processingR E Olson, R A Copeland, D Seiffert
Analytical Biochemistry|September 14, 2001
A method for defining binding sites involved in protein-protein interactions: analysis of the binding of plasminogen activator inhibitor 1 to the somatomedin domain of vitronectinG Royle, G Deng, D Seiffert, et al.
Psychological Reports|August 1, 1970
GSR conditioning and pseudoconditioning with prolonged practiceM C Morrow, P D Seiffert, L L Kramer
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Blood|July 15, 1996
Two functionally distinct pools of vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granulesD Seiffert, R R Schleef
Biochimica Et Biophysica Acta|May 30, 1991
Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectinD Seiffert, D J Loskutoff
Thrombosis Research|June 4, 1998
Role of vitronectin and its receptors in haemostasis and vascular remodelingK T Preissner, D Seiffert
Applied Microbiology and Biotechnology|May 1, 1993
Biosafety investigations in an r-DNA production plantE K Weibel, B D Seiffert
Gene|December 8, 1993
Organization of the gene encoding mouse vitronectinD Seiffert, J Poenninger, B R Binder
The Journal of Cell Biology|September 1, 1990
Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitorD Seiffert, N N Wagner, D J Loskutoff
Histochemistry and Cell Biology|March 1, 1996
Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytesD Seiffert, G M Bordin, D J Loskutoff
Current Opinion in Drug Discovery & Development|December 1, 2001
Progress towards testing the amyloid hypothesis: inhibitors of APP processingR E Olson, R A Copeland, D Seiffert
Analytical Biochemistry|September 14, 2001
A method for defining binding sites involved in protein-protein interactions: analysis of the binding of plasminogen activator inhibitor 1 to the somatomedin domain of vitronectinG Royle, G Deng, D Seiffert, et al.
Psychological Reports|August 1, 1970
GSR conditioning and pseudoconditioning with prolonged practiceM C Morrow, P D Seiffert, L L Kramer
Pageof 6